Position in IMTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$230,842
+$6,609 QoQ
Shares Held
22,788
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#64
of 83 holders
Holding Since
Sep 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMTX Over Time
Shares Held
Position Value (USD)
Derivatives in IMTX
reported options exposure · as of Jun 30, 2025CallValue
$13
CallShares
26,984
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026J. Goldman & Co LP holds $154,729,761 across 52 Biotechnology names. IMTX ranks #50 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
637,994 | $24,690,367 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
38,698 | $11,649,258 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
427,321 | $10,289,889 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
601,972 | $8,132,641 | |
| 5 | ARDX |
Ardelyx, Inc.
|
1,579,828 | $8,057,122 | |
| 6 | URGN |
UroGen Pharma Ltd.
|
212,775 | $7,830,120 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,311 | $6,115,243 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
112,129 | $5,690,546 |
All Filings in IMTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $230,842 | 22,788 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $224,233 | 22,788 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $239,274 | 22,788 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $194,153 | 22,788 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13 | 26,984 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $122,599 | 22,788 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $102,773 | 22,788 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $480 | 26,984 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $162,022 | 22,788 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $6,106 | 26,984 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $307,887 | 26,984 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $260,011 | 22,788 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $343,231 | 29,538 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $313,554 | 26,984 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $283,601 | 26,984 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $658,262 | 62,632 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $781,650 | 67,500 | Call | Sole | 2023-11-14 | |
| 2022-09-30 | $269,840 | 26,984 | Call | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||